Phototherapy for Cutaneous T-Cell Lymphoma

Area of Science:

• Dermatology
• Oncology
• Photobiology

Background:

• Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma.
• Phototherapy, including psoralen and ultraviolet A (PUVA) and narrowband-UVB (NBUVB), is a standard treatment for early-stage MF.
• Establishing clear phototherapy protocols is crucial for effective MF management.

Purpose of the Study:

• To provide practical guidelines for designing and implementing phototherapy protocols for early-stage mycosis fungoides (MF).
• To offer an overview of treatment phases, response criteria, and light source selection for MF phototherapy.
• To discuss evolving research topics in MF phototherapy.

Main Methods:

• Review of current phototherapy practices for mycosis fungoides.
• Guideline development for treatment protocols, including phases and response assessment.
• Discussion of comparative efficacy, maintenance therapy, photocarcinogenicity, and combination treatments.

Main Results:

• Phototherapy with PUVA or NBUVB is a cornerstone for patch and plaque MF.
• Guidelines address protocol design, treatment progression, and outcome evaluation.
• Emerging research explores PUVA vs. NBUVB efficacy, maintenance strategies, and risks.

Conclusions:

• Effective phototherapy protocols are essential for managing early-stage mycosis fungoides.
• Careful selection of light sources and treatment parameters optimizes outcomes.
• Ongoing research will further refine phototherapy approaches for MF.